TUESDAY, March 25 (HealthDay News) -- The use of a less invasive form of sentinel lymph node biopsy (SLNB) during breast cancer surgery increased substantially in the United States from 1998 to 2005, researchers say. However, there are still disparities in terms of which women receive the therapy.

FRIDAY, March 21 (HealthDay News) -- Mutations in a gene called GIGYF2 may be directly linked to the development of Parkinson's disease in families with a history of the neurodegenerative condition, U.S. researchers report.

WEDNESDAY, Feb. 20 (HealthDay News) -- Listening to music for a few hours a day can help boost a stroke patient's early recovery, according to Finnish researchers.

The U.S. Food and Drug Administration has approved Abilify (aripiprazole) as an add-on therapy for people with major depressive disorder who don't benefit enough from antidepressant therapy alone, its makers said Tuesday.
Abilify, approved in November 2002 to treat schizophrenia, is among a class of medications called atypical antipsychotics. The latest approval followed clinical studies involving 743 patients.
Elderly people with dementia-related psychosis who are treated with atypical antipsychotics are at greater risk of death, drug maker Bristol-Myers Squibb warned in a statement.